PER 3.80% 7.6¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-456

  1. 1,067 Posts.
    lightbulb Created with Sketch. 498
    At the risk of stating the obvious, my guess here is that it's Pfizer that want us to use their CRO and that the trial will involve a dystrophin-reducing combination arm.

    i.e. Pfizer want to get the jump on Sarepta; we're the best way to achieve that.

    Obviously this guess should be consumed with bags of salt, because I'm a little (ok, very!) excited haha

    Good luck guys!

    p.s. I keep losing the monster truck races with little mate. The competition's brutal on our driveway.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
-0.003(3.80%)
Mkt cap ! $68.51M
Open High Low Value Volume
7.8¢ 7.8¢ 7.5¢ $47.57K 622.6K

Buyers (Bids)

No. Vol. Price($)
1 1598 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 140942 2
View Market Depth
Last trade - 16.10pm 08/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.